Cargando…
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
BACKGROUND: Patients with locally advanced bladder cancer (cT3/4 cN0/N+ cM0) have a poor prognosis despite radical surgical therapy and perioperative chemotherapy. Preliminary data suggest that the combination of radiation and immunotherapy does not lead to excess toxicity and may have synergistic (...
Autores principales: | Schmid, Sebastian C., Koll, Florestan J., Rödel, Claus, Maisch, Philipp, Sauter, Andreas, Beckert, Franziska, Seitz, Anna, Kübler, Hubert, Flentje, Michael, Chun, Felix, Combs, Stephanie E., Schiller, Kilian, Gschwend, Jürgen E., Retz, Margitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942254/ https://www.ncbi.nlm.nih.gov/pubmed/31900121 http://dx.doi.org/10.1186/s12885-019-6503-6 |
Ejemplares similares
-
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer
por: Wagner, Julia, et al.
Publicado: (2022) -
Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC)
por: Koll, Florestan J., et al.
Publicado: (2021) -
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy
por: Lunger, Lukas, et al.
Publicado: (2020) -
Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013) -
Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study
por: Schmid, Sebastian C., et al.
Publicado: (2015)